Catalyst Wire Dossier Catalyst Wire Dossier

Xeruborbactam (QPX7728)

Xeruborbactam · Qpex Biopharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xeruborbactam (QPX7728), covering 2025-08-29 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male Participants [Phase 1]

See pricing